Biostax Corp. (BTAX)
- Previous Close
0.0472 - Open
0.0472 - Bid --
- Ask --
- Day's Range
0.0472 - 0.0472 - 52 Week Range
0.0450 - 0.9000 - Volume
1 - Avg. Volume
2,898 - Market Cap (intraday)
3.952M - Beta (5Y Monthly) 0.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Biostax Corp. operates as a biopharmaceutical company that acquires and develops immune restoration pharmaceutical and medical technology products. The company was formerly known as Immune Therapeutics, Inc. and changed its name to Biostax Corp. in October 2023. Biostax Corp. is based in Winter Park, Florida.
www.biostaxcorp.comRecent News: BTAX
Performance Overview: BTAX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BTAX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BTAX
Valuation Measures
Market Cap
3.95M
Enterprise Value
5.11M
Trailing P/E
1.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-3.47
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-108.73%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.65M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
29.79k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-357.8k
Company Insights: BTAX
BTAX does not have Company Insights